2024-11-19 18:43:04
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program
Corporate/ 2023-07-23
BioVaxys Enters Agreement With Inotiv To...

VANCOUVER,BC,March 18,2021-- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"),the world leader in hapteni...

Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders
Corporate/ 2023-07-23
Samsung Biologics Unveils Strong Perform...

INCHEON,South Korea,March 19,2021-- Samsung Biologics (KRX: 207940.KS) announced a strong year in 2020 as it reported 1 trillion won in targ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release